vs
ACCESS Newswire Inc.（ACCS）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是ACCESS Newswire Inc.的163.9倍（$950.5M vs $5.8M）。Astrana Health, Inc.净利率更高（0.7% vs -9.9%，领先10.6%）。Astrana Health, Inc.同比增速更快（42.9% vs -0.5%）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 2.0%）
ACCESS通讯社是一家新闻通稿分发服务商，总部位于芝加哥，1954年成立，最初通过电传设备为企业向新闻机构电子传输新闻稿，创始人赫伯特·穆舍勒曾在曼哈顿家中运营该业务长达15年，公司几经转手后，于2015年被Cision集团宣布收购。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
ACCS vs ASTH — 直观对比
营收规模更大
ASTH
是对方的163.9倍
$5.8M
营收增速更快
ASTH
高出43.4%
-0.5%
净利率更高
ASTH
高出10.6%
-9.9%
两年增速更快
ASTH
近两年复合增速
2.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $5.8M | $950.5M |
| 净利润 | $-576.0K | $6.6M |
| 毛利率 | 77.4% | — |
| 营业利润率 | -13.1% | 1.9% |
| 净利率 | -9.9% | 0.7% |
| 营收同比 | -0.5% | 42.9% |
| 净利润同比 | 94.4% | 184.4% |
| 每股收益（稀释后） | $-0.16 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACCSASTH
| Q4 25 | $5.8M | $950.5M | ||
| Q3 25 | $5.7M | $956.0M | ||
| Q2 25 | $5.6M | $654.8M | ||
| Q1 25 | $5.5M | $620.4M | ||
| Q4 24 | $5.8M | $665.2M | ||
| Q3 24 | $5.6M | $478.7M | ||
| Q2 24 | $6.0M | $486.3M | ||
| Q1 24 | $5.6M | $404.4M |
净利润ACCSASTH
| Q4 25 | $-576.0K | $6.6M | ||
| Q3 25 | $-45.0K | $373.0K | ||
| Q2 25 | $-475.0K | $9.4M | ||
| Q1 25 | $5.4M | $6.7M | ||
| Q4 24 | $-10.2M | $-7.8M | ||
| Q3 24 | $-466.0K | $16.1M | ||
| Q2 24 | $7.0K | $19.2M | ||
| Q1 24 | $-139.0K | $14.8M |
毛利率ACCSASTH
| Q4 25 | 77.4% | — | ||
| Q3 25 | 74.6% | — | ||
| Q2 25 | 76.2% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 75.2% | — | ||
| Q3 24 | 75.0% | — | ||
| Q2 24 | 77.2% | — | ||
| Q1 24 | 75.1% | — |
营业利润率ACCSASTH
| Q4 25 | -13.1% | 1.9% | ||
| Q3 25 | -3.2% | 2.0% | ||
| Q2 25 | -4.4% | 3.1% | ||
| Q1 25 | -12.4% | 3.3% | ||
| Q4 24 | -245.8% | 0.1% | ||
| Q3 24 | -10.7% | 5.9% | ||
| Q2 24 | -8.8% | 6.2% | ||
| Q1 24 | -15.5% | 7.5% |
净利率ACCSASTH
| Q4 25 | -9.9% | 0.7% | ||
| Q3 25 | -0.8% | 0.0% | ||
| Q2 25 | -8.5% | 1.4% | ||
| Q1 25 | 98.4% | 1.1% | ||
| Q4 24 | -175.0% | -1.2% | ||
| Q3 24 | -8.3% | 3.4% | ||
| Q2 24 | 0.1% | 3.9% | ||
| Q1 24 | -2.5% | 3.7% |
每股收益（稀释后）ACCSASTH
| Q4 25 | $-0.16 | $0.12 | ||
| Q3 25 | $-0.01 | $0.01 | ||
| Q2 25 | $-0.12 | $0.19 | ||
| Q1 25 | $1.40 | $0.14 | ||
| Q4 24 | $-2.66 | $-0.14 | ||
| Q3 24 | $-0.12 | $0.33 | ||
| Q2 24 | $0.00 | $0.40 | ||
| Q1 24 | $-0.04 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $429.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $30.3M | $779.3M |
| 总资产 | $42.0M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACCSASTH
| Q4 25 | $3.0M | $429.5M | ||
| Q3 25 | $3.3M | $463.4M | ||
| Q2 25 | — | $342.1M | ||
| Q1 25 | — | $260.9M | ||
| Q4 24 | $4.1M | $290.8M | ||
| Q3 24 | — | $350.3M | ||
| Q2 24 | — | $327.7M | ||
| Q1 24 | — | $337.3M |
股东权益ACCSASTH
| Q4 25 | $30.3M | $779.3M | ||
| Q3 25 | $30.8M | $775.5M | ||
| Q2 25 | $30.7M | $765.5M | ||
| Q1 25 | $30.9M | $745.4M | ||
| Q4 24 | $25.2M | $712.7M | ||
| Q3 24 | $35.3M | $704.6M | ||
| Q2 24 | $35.4M | $678.9M | ||
| Q1 24 | $35.2M | $653.5M |
总资产ACCSASTH
| Q4 25 | $42.0M | $2.2B | ||
| Q3 25 | $44.0M | $2.2B | ||
| Q2 25 | $45.6M | $1.4B | ||
| Q1 25 | $47.3M | $1.3B | ||
| Q4 24 | $50.6M | $1.4B | ||
| Q3 24 | $61.7M | $1.3B | ||
| Q2 24 | $62.8M | $1.3B | ||
| Q1 24 | $64.4M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $258.0K | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-6.0M |
| 自由现金流率自由现金流/营收 | — | -0.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | -0.44× |
| 过去12个月自由现金流最近4个季度 | — | $104.5M |
8季度趋势，按日历期对齐
经营现金流ACCSASTH
| Q4 25 | $258.0K | $-2.9M | ||
| Q3 25 | $-582.0K | $10.0M | ||
| Q2 25 | $135.0K | $90.9M | ||
| Q1 25 | $747.0K | $16.6M | ||
| Q4 24 | $866.0K | $-10.9M | ||
| Q3 24 | $1.5M | $34.0M | ||
| Q2 24 | $-190.0K | $23.2M | ||
| Q1 24 | $986.0K | $6.0M |
自由现金流ACCSASTH
| Q4 25 | — | $-6.0M | ||
| Q3 25 | $-590.0K | $7.4M | ||
| Q2 25 | — | $89.5M | ||
| Q1 25 | $735.0K | $13.6M | ||
| Q4 24 | — | $-13.5M | ||
| Q3 24 | $1.5M | $31.7M | ||
| Q2 24 | — | $20.4M | ||
| Q1 24 | $970.0K | $5.6M |
自由现金流率ACCSASTH
| Q4 25 | — | -0.6% | ||
| Q3 25 | -10.3% | 0.8% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | 13.4% | 2.2% | ||
| Q4 24 | — | -2.0% | ||
| Q3 24 | 26.5% | 6.6% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | 17.4% | 1.4% |
资本支出强度ACCSASTH
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.2% | 0.5% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.1% | 0.5% | ||
| Q2 24 | 0.0% | 0.6% | ||
| Q1 24 | 0.3% | 0.1% |
现金转化率ACCSASTH
| Q4 25 | — | -0.44× | ||
| Q3 25 | — | 26.69× | ||
| Q2 25 | — | 9.65× | ||
| Q1 25 | 0.14× | 2.48× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | -27.14× | 1.21× | ||
| Q1 24 | — | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACCS
| Cost To Deliver Products | $3.1M | 54% |
| Employee Costs | $1.7M | 29% |
| Other | $1.0M | 17% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
